Grifols (GRFS) Restructuring Costs (2022 - 2023)
Grifols' (GRFS) quarterly Restructuring Costs came in at $171022.8 in Q4 2023, up 364.68% YoY from $36804.4 in Q4 2022, and up 364.68% on a QoQ basis from $36804.4 in Q4 2022.
Grifols (GRFS) Restructuring Costs (2022 - 2023) Analysis & Trends
Grifols (GRFS) has 2 years of Restructuring Costs data on file, last reported at $171022.8 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.97 Bn | 633.21 Bn | 17.26 Bn |
| 2 | AbbVie | 470.43 Bn | 463.86 Bn | 12.70 Bn |
| 3 | Merck | 376.87 Bn | 369.73 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.36 Bn | 295.67 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.56 Bn | 252.66 Bn | 12.86 Bn |
| 6 | Amgen | 236.76 Bn | 222.77 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.01 Bn | 178.83 Bn | 6.22 Bn |
| 8 | Pfizer | 159.37 Bn | 147.67 Bn | 10.94 Bn |
| 9 | Gsk | 106.08 Bn | 101.91 Bn | 8.24 Bn |
| 10 | Grifols | 5.44 Bn | 4.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 171,022.80 |
| Dec 31, 2022 | 36,804.40 |